Verastem financial statements

베라스템NASDAQ:VSTM · Nasdaq · Healthcare
$7.70-2.53%
2026-10-02 close

Verastem's published financial data is dated 2026-10-04. 2024 revenue was $10M. 2024 operating profit was −$115M.

Reported results

Verastem notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q